Your browser doesn't support javascript.
loading
The protein phosphatase 2A regulatory subunit PR70 is a gonosomal melanoma tumor suppressor gene.
van Kempen, Léon C L; Redpath, Margaret; Elchebly, Mounib; Klein, Kathleen Oros; Papadakis, Andreas I; Wilmott, James S; Scolyer, Richard A; Edqvist, Per-Henrik; Pontén, Fredrik; Schadendorf, Dirk; van Rijk, Anke F; Michiels, Stefan; Dumay, Anne; Helbling-Leclerc, Anne; Dessen, Philippe; Wouters, Jasper; Stass, Marguerite; Greenwood, Celia M T; Ghanem, Ghanem E; van den Oord, Joost; Feunteun, Jean; Spatz, Alan.
Afiliación
  • van Kempen LC; Department of Pathology, McGill University, Montreal, Quebec, Canada.
  • Redpath M; Lady Davis Institute for Medical Research, Montreal, Quebec, Canada.
  • Elchebly M; Department of Pathology, McGill University, Montreal, Quebec, Canada.
  • Klein KO; Lady Davis Institute for Medical Research, Montreal, Quebec, Canada.
  • Papadakis AI; Lady Davis Institute for Medical Research, Montreal, Quebec, Canada.
  • Wilmott JS; Lady Davis Institute for Medical Research, Montreal, Quebec, Canada.
  • Scolyer RA; Department of Pathology, McGill University, Montreal, Quebec, Canada.
  • Edqvist PH; Lady Davis Institute for Medical Research, Montreal, Quebec, Canada.
  • Pontén F; Melanoma Institute Australia, Royal Prince Alfred Hospital, and University of Sydney, Sydney, New South Wales, Australia.
  • Schadendorf D; Melanoma Institute Australia, Royal Prince Alfred Hospital, and University of Sydney, Sydney, New South Wales, Australia.
  • van Rijk AF; Department of Immunology, Genetics and Pathology, and Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
  • Michiels S; Department of Immunology, Genetics and Pathology, and Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
  • Dumay A; Department of Dermatology, University Hospital Essen, Essen, Germany.
  • Helbling-Leclerc A; German Cancer Consortium (DKTK), Heidelberg, Germany.
  • Dessen P; Lady Davis Institute for Medical Research, Montreal, Quebec, Canada.
  • Wouters J; Service de Biostatistique et d'Epidémiologie, Gustave Roussy, Villejuif, France.
  • Stass M; Centre for Research in Epidemiology and Population Health (CESP), INSERM, UMR 1018, Université Paris-Sud, Kremlin-Bicetre, France.
  • Greenwood CM; Centre de Recherche sur l'Inflammation, INSERM, UMR S 1149, Labex Inflamex, Université Paris-Diderot Sorbonne Paris-Cité, Paris, France.
  • Ghanem GE; CNRS, UMR 8200, Université Paris-Sud, Villejuif, France.
  • van den Oord J; CNRS UMR 8200, Universite Paris-Sud, Gustave Roussy, Villejuif, France.
  • Feunteun J; Hématopoïèse normale et pathologique, INSERM UMR 1170, Université Paris-Sud, Gustave Roussy, Villejuif, France.
  • Spatz A; Laboratory of Translational Cell and Tissue Research, KU Leuven, Leuven, Belgium.
Sci Transl Med ; 8(369): 369ra177, 2016 12 14.
Article en En | MEDLINE | ID: mdl-27974665
Buscar en Google
Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Proteínas Nucleares / Proteínas de Ciclo Celular / Proteína Fosfatasa 2 / Melanoma Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans / Male Idioma: En Revista: Sci Transl Med Asunto de la revista: CIENCIA / MEDICINA Año: 2016 Tipo del documento: Article País de afiliación: Canadá
Buscar en Google
Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Proteínas Nucleares / Proteínas de Ciclo Celular / Proteína Fosfatasa 2 / Melanoma Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans / Male Idioma: En Revista: Sci Transl Med Asunto de la revista: CIENCIA / MEDICINA Año: 2016 Tipo del documento: Article País de afiliación: Canadá